US Equity

Stock has been in a downtrend since 2014.

AbbVie Is Flexing Its Abs Real Money Pro($)

ABBV is now set up well for more upside.
After-hours releases could have impact.
Whatever is driving it, V's charts are pointed higher.
Our DSE is flashing a bold warning right now.
Medtronic, Abbott Labs and Becton Dickinson appear to be offering buying opportunities.
Microsoft, Intel, Alphabet and Amazon are among the big-cap names that will report after the bell.
Let's pull the band aid off the charts, carefully.
Traders looking to get long TRV should buy strength.
Try this GDX out-of-the-money, bullishly biased vertical call spread.


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.